Keeps Biopharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	129,303	208,813	97,681	119,991	127,866	235,610
Market Cap Growth	-35.48%	113.77%	-18.59%	-6.16%	-45.73%	-23.77%
Enterprise Value	211,614	254,805	122,355	160,512	124,281	215,414
Last Close Price	6440.00	10400.00	5210.00	6400.00	6820.00	13100.00
PE Ratio	-	-	87.73	30.53	-	-
Forward PE	-	3.21	3.21	3.21	3.21	3.21
PS Ratio	0.68	1.23	0.77	1.30	8.75	55.30
PB Ratio	1.52	2.56	1.54	2.05	2.45	3.87
P/TBV Ratio	9.02	19.72	10.43	4.50	2.45	3.92
P/OCF Ratio	-	-	20.31	-	-	-
EV/Sales Ratio	1.12	1.50	0.96	1.74	8.50	50.56
EV/EBITDA Ratio	56.23	42.03	13.89	35.65	-	-
EV/EBIT Ratio	-	161.82	19.65	52.45	-	-
Debt / Equity Ratio	1.11	1.14	0.88	0.83	0.55	0.45
Debt / EBITDA Ratio	17.13	15.27	6.33	10.73	-	-
Net Debt / Equity Ratio	0.75	0.81	0.52	0.64	0.07	-0.22
Net Debt / EBITDA Ratio	11.52	10.89	3.72	8.31	-0.46	1.16
Net Debt / FCF Ratio	-1.49	-1.41	-18.32	-35.68	-3.76	1.57
Asset Turnover	0.89	0.85	0.90	0.91	0.16	0.05
Inventory Turnover	5.74	5.10	8.57	22.90	7.05	4.01
Quick Ratio	0.68	0.54	0.46	0.40	0.99	1.59
Current Ratio	1.26	1.15	0.82	0.84	1.35	2.10
Return on Equity (ROE)	-4.19%	-14.33%	2.64%	6.25%	-21.28%	-29.03%
Return on Assets (ROA)	0.24%	0.49%	2.74%	1.89%	-6.23%	-9.03%
Return on Invested Capital (ROIC)	0.55%	1.29%	3.10%	2.60%	-17.23%	-28.11%
Return on Capital Employed (ROCE)	0.50%	1.10%	7.70%	5.00%	-16.70%	-19.50%
Earnings Yield	-1.84%	-4.69%	1.14%	3.28%	-8.90%	-6.50%
FCF Yield	-33.01%	-22.44%	-1.83%	-0.87%	-0.75%	-3.60%
Buyback Yield / Dilution	-5.60%	-3.95%	-0.31%	-0.40%	-8.22%	-18.22%